CEO’s $1.3M Bet Could Send This Stock Flying

CEO's $1.3M Bet: Insider Signal for Animal Health Stock‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

"CEO's insider buy could send this stock soaring." Karim Rahemtulla, Head Fundamental Tactician, Monument Traders Alliance Despite the recent bounce we've seen in equities, there still remains a great deal of uncertainty, stemming from geopolitical risks, Fed policy actions, and upcoming economic data releases. If there is one thing the market hates, it's uncertainty. Which is why it's critical to trade with an edge. And why I'm closely following legal insider trading. You see, insiders, particularly company executives, often have unparalleled knowledge about their organization's health and future. When they buy shares of their own company, it's usually for one reason - they believe the stock price will rise. Very few things can give investors more confidence than when a CEO goes into the open market and publicly buys shares of his company's stock. Which is what happened in Elanco Animal Health Incorporated (ELAN) On August 12, 2024 the company's CEO Jeffery N. Simmons bought 100,000 shares at an average cost of $13.01. Zero Day Options Trade LIVE Tuesday, August 20 at 2 p.m. ET! When The Gov't Drops Economic Reports... This One Trade Could Have Made 253%... 327%... Even 383% gains... Enough for overnight payouts of $25,300... $32,700... heck even $38,300! Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!) I believe ELAN is a worthy candidate to add to your watchlist for a number of reasons. Elanco is a global leader in animal health, providing a wide range of products for both pets and livestock. Their pipeline is particularly strong, focusing on high-demand areas like pet parasiticides, dermatology treatments, and alternatives to antibiotics in livestock. With innovative products like Credelio Quattro for pets and Increxxa for farm animals in development or expansion, Elanco is well-positioned to capitalize on growing market needs. This robust pipeline, combined with their commitment to sustainability and digital health solutions, suggests significant growth potential in the animal health sector. Now, the last time its CEO bought shares in the open market was March 10, 2023. His average price for that purchase was $9.59. Within five months from that purchase shares shot up by 30%. And a year later they were up 88%. It's hard to bet against him based on that track record. Action Plan: Keep an eye on ELAN and look for a potential entry on a pullback. Shares shot up significantly on Tuesday following the insider buy, but based on the CEO's track record, this could just be the start of a bigger move. Trading with an edge is critical in this market, and that's why we track and trade off insider activity in The War Room. If you'd like to learn more about what we're doing in the portfolio, make sure to click here to find out. You're Invited: Meet S.A.M. The Next-Gen AI Tool Multimillionaire trader who turned $37K into $2.7 million in just 4 years is hosting a summit to reveal his revolutionary new AI trading research tool "S.A.M." See how it could have unlocked top gains of up to 219%, 326% and 2,250% within 9 days or less! >> SEE S.A.M. in Action << Monument Traders Alliance   You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day. © 2024 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.